You are here

Poseida Therapeutics

It’s official: Roche is a Car-T player

EP Vantage

Wed, 08/3/22 - 10:42 am

Poseida Therapeutics

Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on the shelf

Fierce Biotech

Wed, 11/10/21 - 10:22 am

Poseida Therapeutics

Poseida, Takeda partner to develop eight in vivo gene therapy programs

Pharmaceutical Business Review

Wed, 10/13/21 - 10:51 am

Poseida Therapeutics

drug development

A year after a death and accompanying trial hold, Poseida hopes for reprieve with early solid tumor CAR-T data

Fierce Biotech

Tue, 08/31/21 - 11:05 am

Poseida Therapeutics

clinical trials

A couple months after landing $100 million in funding, Cellares grabs partner for its Cell Shuttle

Endpoints

Wed, 07/14/21 - 10:15 am

Poseida Therapeutics

Poseida shares plunge after death in solid tumor CAR-T trial, clinical hold

Fierce Biotech

Tue, 08/18/20 - 11:05 pm

Poseida Therapeutics

prostate cancer

3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments

Xconomy

Mon, 07/13/20 - 11:33 pm

Nkarta Therapeutics

Poseida Therapeutics

Another four biotechs scratch out the first number and ask for more as IPO boom continues

Endpoints

Fri, 07/10/20 - 11:00 am

Relay Therapeutics

Nkarta Therapeutics

Poseida Therapeutics

Poseida Therapeutics guns again for IPO

Fierce Biotech

Mon, 06/22/20 - 10:32 am

Poseida Therapeutics

CAR-T Drugmaker Poseida Snags $142 Million in Financing Led by Novartis

BioSpace

Mon, 04/22/19 - 10:12 am

Poseida Therapeutics

Poseida pitches a $115M IPO on its claim that the science team has created a better BCMA CAR-T

Endpoints

Sun, 01/6/19 - 01:58 pm

Poseida Therapeutics

Poseida Therapeutics Prepares for IPO to Advance CAR-T Treatments

Xconomy

Sat, 01/5/19 - 12:11 am

Poseida Therapeutics